Cargando…
Do biologic therapies reduce aortic inflammation in rheumatoid arthritis patients?
OBJECTIVES: Rheumatoid arthritis (RA) patients have an increased risk of cardiovascular disease (CVD). In the present study, we evaluated the inflammatory activity of the ascending aorta in RA patients who received biological treatment. METHODS: We assessed the aortic wall inflammation of RA patient...
Autores principales: | Trang, D. A. M. Thuy, Okamura, Koichi, Suto, Takahito, Sakane, Hideo, Yonemoto, Yukio, Nakajima, Takahito, Tsushima, Yoshito, Chikuda, Hirotaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330127/ https://www.ncbi.nlm.nih.gov/pubmed/34344436 http://dx.doi.org/10.1186/s13075-021-02585-w |
Ejemplares similares
-
Does periodontitis affect the treatment response of biologics in the treatment of rheumatoid arthritis?
por: Tachibana, Masahiro, et al.
Publicado: (2020) -
Shoulder tenderness was associated with the inflammatory changes on magnetic resonance imaging in patients with rheumatoid arthritis
por: Shinagawa, Satoshi, et al.
Publicado: (2019) -
Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
por: Kaneko, Tetsuya, et al.
Publicado: (2019) -
Anti-drug antibodies and rheumatoid factor level in patients with rheumatoid arthritis using the infliximab biosimilar CT-P13
por: Sakane, Hideo, et al.
Publicado: (2022) -
The impact of bDMARDs on postoperative complications in patients with rheumatoid arthritis: A systematic review and meta-analysis
por: Suto, Takahito, et al.
Publicado: (2023)